Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 12, 2024
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 05, 2023
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 16, 2023
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 18, 2022
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.
Journal: JTO clinical and research reports
Published: July 06, 2022
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.
Journal: The New England journal of medicine
Published: June 03, 2022
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 11, 2022
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: September 17, 2021
Mobocertinib: A Potential Treatment for NSCLC with EGFR Exon 20 Insertions.
Journal: Cancer discovery
Published: July 21, 2021
Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system.
Journal: Translational lung cancer research
Published: March 22, 2021
CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 28, 2021
Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD).
Journal: Translational lung cancer research
Published: January 25, 2021
Last Updated: 09/26/2026